Journal of the Korea Society of Computer and Information (한국컴퓨터정보학회논문지)

Korean Society of Computer Information (한국컴퓨터정보학회)
권호 표지
DOI QR코드

DOI QR Code

Effects of Adipokine Retnla on the Regulation of High-Density Lipoprotein Metabolism

  • Lee, Mi-Ran (Dept. of Biomedical Laboratory Science, Jungwon University)
  • Received : 2016.11.23
  • Accepted : 2016.12.08
  • Published : 2016.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

In this paper, we propose to evaluate the effect of Resistin-like molecule alpha (Retnla) on the expression of transporters involved in modulating concentrations of peripheral cholesterol and plasma high-density lipoprotein (HDL) cholesterol. High levels of blood cholesterol are a well-recognized risk factor for atherosclerosis and are eliminated via the process of reverse cholesterol transport (RCT). We recently showed that Retnla ameliorates hypercholesterolemia and atherosclerosis by increasing biliary cholesterol secretion, the final step of the process, in low-density lipoprotein receptor-deficient mice. However, the role of Retnla in HDL-mediated cholesterol efflux, initial step of RCT pathway, is not yet clear. To identify cholesterol transport genes regulated by Retnla, we performed an extensive microarray-based gene expression screen using livers from Retnla-overexpressing (Tg) mice and control animals. The most significant change in Retnla-Tg mice was an upregulation of ATP-binding cassette sub-family G member 4 (Abcg4) transport and was validated using quantitative RT-PCR. The validated gene was also induced by treatment of purified Retnla protein in RAW 264.7 cells incubated with acetylated low-density lipoprotein and Hepa1c1c7 cells. Taken together, these results indicates that Retnla might also accelerate initial step of RCT pathway, suggesting therapeutic value of Retnla in the treatment of hypercholesterolemia and atherosclerosis.

Keywords

References

  1. P. Libby, P. M. Ridker, and G. K. Hansson, "Progress and challenges in translating the biology of atherosclerosis", Nature, Vol. 473, No. 7347, pp. 317-325, May 2011. https://doi.org/10.1038/nature10146
  2. F. Schaftenaar, V. Frodermann, J. Kuiper, and E. Lutgens. "Atherosclerosis: the interplay between lipids and immune cells", Current Opinion in Lipidology, Vol. 27, No. 3, pp. 209-215, Jun. 2016. https://doi.org/10.1097/MOL.0000000000000302
  3. S. J. Rho, H. M. Lee, and K. W. Oh, "Prevalence of hypercholesterolemia among adults over 30 years old in Korea, 2009-2013", Public Health Weekly Report, Vol. 8, No. 36, pp. 857-860, Sep. 2015.
  4. Y. A. Kim, "Status of cholesterol level among adults in Korea, 2008-2011", Public Health Weekly Report, Vol. 7, No. 35, pp. 773-776, Aug. 2014.
  5. S. L. Pinkosky, R. S. Newton, E. A. Day, R. J. Ford, S. Lhotak, R. C. Austin, and et al, "Liver-specific ATP-citrate lyase inhibition by bempedoic acid decreases LDL-C and attenuates atherosclerosis.", Nature Communications, Vol. 7, pp. 13457, Nov. 2016. https://doi.org/10.1038/ncomms13457
  6. T. R. Pedersen, "The Success Story of LDL Cholesterol Lowering", Circulation Research, Vol. 118, No. 4, pp. 721-731, Feb. 2016. https://doi.org/10.1161/CIRCRESAHA.115.306297
  7. J. S. Lee, S. H. Bok, Y. B. Park, M. K. Lee, and M. S. Choi, "4-hydroxycinnamate lowers plasma and hepatic lipids without changing antioxidant enzyme activities", Annals of Nutrition and Metabolism, Vol. 47, No. 3-4, pp. 144-151, May 2003. https://doi.org/10.1159/000070037
  8. Y. Matsuzawa, "Therapy insight: adipocytokines in metabolic syndrome and related ardiovascular disease", Nature Clinical Practice Cardiovascular Medicine, Vol. 3, No. 1, pp. 35-42, Jan. 2006. https://doi.org/10.1038/ncpcardio0380
  9. I. N. Holcomb, R. C. Kabakoff, B. Chan, T. W. Baker, A. Gurney, W. Henzel, and et al. "FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family", The EMBO Journal, Vol. 19, No. 15, pp. 4046-4055, Aug. 2000. https://doi.org/10.1093/emboj/19.15.4046
  10. X. Teng, D. Li, H. C. Champion, and R. A. Johns, "FIZZ1/RELMalpha, a novel hypoxia-induced mitogenic factor in lung with vasoconstrictive and angiogenic properties", Circulation Research, Vol. 92, No. 10, pp. 1065-1067, May 2003. https://doi.org/10.1161/01.RES.0000073999.07698.33
  11. M. R. Lee, D. Shim, J. Yoon, H. S. Jang, S. W. Oh, S. H. Suh, and et al. "Retnla overexpression attenuates allergic inflammation of the airway", PLoS One, Vol. 9, No. 10, pp. e102666, Nov. 2014. https://doi.org/10.1371/journal.pone.0102666
  12. R. A. Johns, E. Takimoto, L. W. Meuchel, E. Elsaigh, A. Zhang, N. M. Heller, and et al. "Host lung immunity is severely compromised during tropical pulmonary eosinophilia: role of lung eosinophils and macrophages", Journal of Leukocyte Biology, Vol. 36, No. 1, pp. 124-144, Jan. 2016.
  13. M. R. Lee, C. J. Lim, Y. H. Lee, J. G. Park, S. K. Sonn, M. N. Lee, and et al. "The adipokine Retnla modulates cholesterol homeostasis in hyperlipidemic mice", Nature Communications, Vol. 5, pp. 4410, Jul. 2014. https://doi.org/10.1038/ncomms5410
  14. B. Blagoev, I. Kratchmarova, M. M. Nielsen, M. M. Fernandez, J. Voldby, J. S. Andersen, and et al. "Inhibition of adipocyte differentiation by resistin-like molecule alpha. Biochemical characterization of its oligomeric nature", The Journal of Biological Chemistry. Vol. 277, No. 44, pp. 42010-42016, Nov. 2002.
  15. G. B. Moore, H. Chapman, J. C. Holder, C. A. Lister, V. Piercy, S. A. Smith, and J. C. Clapham, "Differential regulation of adipocytokine mRNAs by rosiglitazone in db/db mice", Biochemical and Biophysical Research Communications, Vol. 286, No. 4, pp. 735-741, Aug. 2001. https://doi.org/10.1006/bbrc.2001.5460
  16. A. Munitz, L. Seidu, E. T. Cole, R. Ahrens, S. P. Hogan, and M. E. Rothenberg, "Resistin-like molecule alpha decreases glucose tolerance during intestinal inflammation", Vol. 182, No. 4, pp. 2357-2363, Feb. 2009. https://doi.org/10.4049/jimmunol.0803130
  17. N. Wang, D. Lan, W. Chen, F. Matsuura, A. R. Tall, "The E3 ubiquitin ligases, HUWE1 and NEDD4-1, are involved in the post-translational regulation of the ABCG1 and ABCG4 lipid transporters", The Journal of Biological Chemistry, Vol. 290, No. 40, pp. 24604-24612, Oct. 2015. https://doi.org/10.1074/jbc.M115.675579
  18. M. Van Eck, J. Twisk, M. Hoekstra, B. T. Van Rij, C. A. Van der Lans, I. S. Bos, and et al. "Differential effects of scavenger receptor BI deficiency on lipid metabolism in cells of the arterial wall and in the liver", The Journal of Biological Chemistry, Vol. 278, No. 26, pp. 23699-23705, Jun. 2003. https://doi.org/10.1074/jbc.M211233200
  19. M. D. Wang, V. Franklin, M. Sundaram, R. S. Kiss, K. Ho, M. Gallant, and Y. L. Marcel. "Differential regulation of ATP binding cassette protein A1 expression and ApoA-I lipidation by Niemann-Pick type C1 in murine hepatocytes and macrophages", The Journal of Biological Chemistry, Vol. 282, No. 31, pp. 22525-22533, Aug. 2007. https://doi.org/10.1074/jbc.M700326200
  20. K. Isoda, S. Sawada, M. Ayaori, T. Matsuki, R. Horai, Y. Kagata, K. Miyazaki, and et al. "Deficiency of interleukin-1 receptor antagonist deteriorates fatty liver and cholesterol metabolism in hypercholesterolemic mice", The Journal of Biological Chemistry, Vol. 280, No. 8, pp. 7002-7009, Feb. 2005. https://doi.org/10.1074/jbc.M412220200
  21. K. L. Ma, X. Z. Ruan, S. H. Powis, Y. Chen, J. F. Moorhead, and Z. Varghese, "Inflammatory stress exacerbates lipid accumulation in hepatic cells and fatty livers of apolipoprotein E knockout mice", Hepatology, Vol. 48, No. 3, pp. 770-781, Sep. 2008. https://doi.org/10.1002/hep.22423
  22. S. M. Grundy, "Scavenger Receptor B-1 Emerges as Anti-atherogenic Candidate", Cell Metabolism, Vol. 23, No. 5, pp. 755-757, May 2016. https://doi.org/10.1016/j.cmet.2016.04.019
  23. Y. Gui, S. Yao, H. Yan, L. Hu, C. Yu, F. Gao, and et al. "A novel small molecule liver X receptor transcriptional regulator, nagilactone B, suppresses atherosclerosis in apoE-deficient mice." Cardiovascular Research, Vol. 102, No. 1, pp. 502-514, Oct. 2016.